Lifecore Biomedical Inc (LFCR)
5.87
+0.10
(+1.73%)
USD |
NASDAQ |
May 17, 16:00
5.85
-0.02
(-0.34%)
After-Hours: 20:00
Lifecore Biomedical Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2023 | 101.64M |
| February 28, 2023 | 114.96M |
| November 30, 2022 | 146.95M |
| August 31, 2022 | 142.57M |
| May 31, 2022 | 138.18M |
| February 28, 2022 | 119.50M |
| November 30, 2021 | 166.19M |
| August 31, 2021 | 155.83M |
| May 31, 2021 | 193.90M |
| February 28, 2021 | 186.05M |
| November 30, 2020 | 170.19M |
| August 31, 2020 | 173.95M |
| May 31, 2020 | 190.32M |
| February 29, 2020 | 174.76M |
| November 30, 2019 | 180.69M |
| August 31, 2019 | 165.14M |
| May 31, 2019 | 148.98M |
| February 28, 2019 | 143.43M |
| November 30, 2018 | 81.83M |
| August 31, 2018 | 80.06M |
| May 31, 2018 | 69.30M |
| February 28, 2018 | 55.54M |
| November 30, 2017 | 54.77M |
| August 31, 2017 | 56.50M |
| May 31, 2017 | 50.24M |
| Date | Value |
|---|---|
| February 28, 2017 | 48.47M |
| November 30, 2016 | 51.21M |
| August 31, 2016 | 52.00M |
| May 31, 2016 | 57.34M |
| February 29, 2016 | 57.15M |
| November 30, 2015 | 48.21M |
| August 31, 2015 | 40.60M |
| May 31, 2015 | 42.52M |
| February 28, 2015 | 49.79M |
| November 30, 2014 | 47.22M |
| August 31, 2014 | 40.03M |
| May 31, 2014 | 34.37M |
| February 28, 2014 | 35.78M |
| November 30, 2013 | 38.18M |
| August 31, 2013 | 39.97M |
| May 31, 2013 | 44.30M |
| February 28, 2013 | 46.84M |
| November 30, 2012 | 51.73M |
| August 31, 2012 | 53.45M |
| May 31, 2012 | 58.98M |
| February 29, 2012 | 16.50M |
| November 30, 2011 | 17.50M |
| August 31, 2011 | 18.83M |
| May 31, 2011 | 19.83M |
| February 28, 2011 | 20.83M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
101.64M
Minimum
May 2023
193.90M
Maximum
May 2021
157.05M
Average
165.14M
Median
Aug 2019
Total Long Term Debt (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 28.78M |
| SELLAS Life Sciences Group Inc | -- |
| ADMA Biologics Inc | 130.85M |
| Relmada Therapeutics Inc | -- |
| Jaguar Health Inc | 32.11M |